News
Fox Corporation said profit in its fiscal third quarter tumbled due to higher operating expenses despite a windfall of ad ...
FLOWERS.COM's stock is overvalued, with an intrinsic value estimated at $4.69 per share. Click here to find out why I rate ...
Fox (FOX) (FOXA) on Monday surpassed expectations for top and bottom line numbers in its third-quarter earnings report, ...
There has been no shortage of turmoil in the global economy thanks to war – trade and otherwise – and skirmish and terror of ...
Bharti Airtel shares climbed ahead of its Q4 FY25 results set for May 13. Investors await key updates on the record date, ...
This move doesn’t come completely out of the blue: company founder Carl Pei previously confirmed that the next Nothing Phone ...
9hon MSN
Homegrown FMCG player Jyothy Labs reported a soft set of numbers in Q4 FY25, with its consolidated net profit slipping ...
Given the opportunity, the bank can take more risks on its books in personal loans, non-mortgage-based retail loans, loan ...
NVIDIA GB200 NVL72 AI server shipment status: 1500 units were shipped in April alone, compared to just 1000 units than the ...
Ferrari boss Fred Vasseur has attributed Lewis Hamilton's fluctuating results with the team to date in Formula 1 to the ...
15h
Asianet Newsable on MSNTapestry Surprises With Q3 Beat, Annual Forecast Bump: Retail Mood NeutralThe company's report is an outlier as most retail businesses flag weak demand and cost pressures from U.S. trade policies.
Piramal Pharma advanced 2.14% to Rs 212.35 after the company informed that it has received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA) for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results